Recognizing clonal hematopoiesis – diagnostic challenges and clinical relevance
How do targeted treatments for IDH1 and IDH2 mutations work in acute myeloid leukemia (AML)?
Developments in multiple myeloma - immunotherapy and personalized medicine
Mode of action of hypomethylating agents for MDS
Oncogenic mutational networks in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS)